Inovio Pharmaceuticals (INO.Q) announced the publication of the preclinical study data for its COVID-19 DNA vaccine, IN0-4800, demonstrating neutralizing antibody and T-cell immune responses against the coronavirus. It’s neither…
SARS
Roadman Investments’ (LITT.V) recent acquisition target CLOV Biopharma (CBP) is continuing its research into the potential commercial uses of cedar leaf oil vapour (CLOV), specifically when it comes to…